Quantcast

Latest Aminoacyl tRNA synthetase Stories

2011-03-23 20:50:10

A portion of the "code" of life has been unraveled by a UC Santa Barbara graduate student from the town of Jojutla, Mexico. Annia Rodriguez worked with John Perona, professor in UCSB's Department of Chemistry and Biochemistry, to decipher intramolecular communication within a large RNA-protein enzyme responsible for expressing the genetic code for the amino acid glutamine. To their surprise, the experiments by Rodriguez captured a partial glimpse of how the genetic coding of life may have...

2010-06-14 05:00:00

SAN DIEGO, June 14 /PRNewswire/ -- aTyr Pharma, Inc. today announced that Catharine E. Johnson, Ph.D. has recently joined the company as its Senior Vice President of Business Development. Dr. Johnson's extensive biotechnology industry experience will help to advance aTyr Pharma's portfolio of resectin-based therapeutics. Resectins are a novel class of endogenous human proteins derived from aminoacyl tRNA synthetases, and have activities relevant to multiple disease areas, including...

2010-05-25 05:00:00

SAN DIEGO, May 25 /PRNewswire/ -- aTyr announced today that John Mendlein, Ph. D., has joined their Board of Directors as Executive Chairman. The translation of aTyr's newly found class of proteins, resectins, into medicines of the future will benefit from Dr. Mendlein's experience in biologics, partnerships, and product strategy. Resectins may serve as potential replacement protein therapeutics or as targets for antagonists relevant to inflammation, blood disorders, and metabolic...

2009-12-14 12:45:46

The work provides insight into potential therapeutic for cancer and eye diseases Researchers at The Scripps Research Institute have solved a 10-year-old mystery of how a single protein from an ancient family of enzymes can have two completely distinct roles in the body. In addition to providing guidance for understanding other molecules in the family, the research supplies a theoretical underpinning for the protein's possible use for combating diseases including cancer and macular...

2009-12-14 05:00:00

SAN DIEGO, Dec. 14 /PRNewswire/ -- Research published in the December 13, 2009 edition of Nature Structural Biology uncovers the structural basis for the multifunctionality of aminoacyl tRNA synthetases. Aminoacyl tRNA synthetases are universal and essential enzymes of protein synthesis machinery found in all organisms. However, human synthetases and naturally occurring variants of these enzymes have additional activities that are vital to normal functioning of the complex human system...

2009-10-14 05:00:00

SAN DIEGO, Oct. 14 /PRNewswire/ -- aTyr Pharma announced today that Dr. Floyd Bloom Professor Emeritus, Molecular and Integrative Neuroscience Department at The Scripps Research Institute, has joined their scientific advisory board. A widely acknowledged leader in the field of neurosciences, Dr. Bloom has been recognized with many honors, including elected membership to the National Academy of Sciences, the Institute of Medicine, the American Philosophical Society and the Royal Swedish...

2009-10-07 05:00:00

SAN DIEGO, Oct. 7 /PRNewswire/ -- aTyr Pharma, Inc., a biopharmaceutical company discovering and developing a new class of naturally occurring proteins as biotherapeutics, will present at the BioPartnering Europe Conference in London on Monday October 12. Jeff Watkins, CEO of aTyr Pharma, will provide an overview of aTyr Pharma's technology, product engine, and lead program based on naturally occurring resected proteins of the tRNA synthetases. The aminoacyl tRNA synthetases are...

2009-09-29 05:00:00

SAN DIEGO, Sept. 29 /PRNewswire/ -- aTyr Pharma announced today that Professor Osamu Nureki, Department of Basic Medical Sciences of the Institute of Medical Science at the University of Tokyo, has joined their scientific advisory board. A globally-recognized expert in protein crystallography, Professor Nureki is well known for his contributions in elucidating the structures of aminoacyl tRNA synthetases. The tRNA synthetases are key enzymes in protein synthesis, but have recently...

2009-09-24 13:23:00

SAN DIEGO, Calif., Sept. 24 /PRNewswire/ -- aTyr Pharma, Inc., a biopharmaceutical company discovering and developing a new class of naturally occurring proteins as biotherapeutics, will present at the Japan Biopharma Conference in Tokyo on Tuesday October 6. Jeff Watkins, CEO of aTyr Pharma, will provide an overview of aTyr Pharma's technology, product engine, and lead program based on naturally occurring resected proteins of the tRNA synthetases. The aminoacyl tRNA synthetases are...

2009-09-14 12:28:00

SAN DIEGO, Sept. 14 /PRNewswire/ -- aTyr Pharma, Inc., a biopharmaceutical company discovering and developing a new class of naturally occurring proteins as biotherapeutics, will present at the BioPharm America 2009 conference in San Francisco, CA on Friday, September 18th. Jeff Watkins, CEO of aTyr Pharma, will present an overview of aTyr Pharma's technology, product engine, and lead program based on naturally occurring resected proteins of the tRNA synthetases. The aminoacyl tRNA...


Word of the Day
baudekin
  • A rich embroidered or brocaded silk fabric woven originally with a warp of gold thread.
'Baudekin' seems to be an alternative form of 'baldachin,' from the Italian 'Baldacco,' Baghdad, the city where the material was made.
Related